-
1
-
2
-
3
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group stud...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
4
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the AT...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
18
-
19
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction ca...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
20